PanTHERA CryoSolutions

Edmonton, Canada Founded: 2018 • Age: 8 yrs Acquired By BioLife Solutions
Cryopreservation platform for cells, tissues, and organs is provided.
Request Access

About PanTHERA CryoSolutions

PanTHERA CryoSolutions is a company based in Edmonton (Canada) founded in 2018 by Jason Acker and Robert Ben was acquired by BioLife Solutions in April 2025.. PanTHERA CryoSolutions has raised $6 million across 2 funding rounds from investors including BioLife Solutions and Casdin Capital. PanTHERA CryoSolutions offers products and services including Ice Recrystallization Inhibitors. PanTHERA CryoSolutions operates in a competitive market with competitors including Brooks Automation, Bridge to Life, Hemanext, Atelerix and Cellbox Solutions, among others.

  • Headquarter Edmonton, Canada
  • Founders Jason Acker, Robert Ben
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $6 M (USD)

    in 2 rounds

  • Latest Funding Round
    $4 M (USD), Series A

    Jan 25, 2021

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    BioLife Solutions

    (Apr 07, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of PanTHERA CryoSolutions

PanTHERA CryoSolutions offers a comprehensive portfolio of products and services, including Ice Recrystallization Inhibitors. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Products that reduce ice damage and improve cell recovery in freezing processes.

People of PanTHERA CryoSolutions
Headcount 1-10
Employee Profiles 5
Board Members and Advisors 3
Employee Profiles
People
Jason Acker
President & CEO
People
Ilias Mahmud
Senior R&D Synthetic Organic Chemist
People
Robert Ben
Chief Scientific Officer
People
Jasper Quartus
Synthetic Organic Chemist

Unlock access to complete

Board Members and Advisors
people
Peter Lee
Board Member
people
Aby Mathew
Board Member
people
Erik Woods
Board Member

Unlock access to complete

Funding Insights of PanTHERA CryoSolutions

PanTHERA CryoSolutions has successfully raised a total of $6M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $4.0M
  • First Round

    (03 Dec 2020)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2021 Amount Series A - PanTHERA CryoSolutions Valuation Casdin Capital , BioLife Solutions
Dec, 2020 Amount Seed - PanTHERA CryoSolutions Valuation Casdin Capital , BioLife Solutions
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in PanTHERA CryoSolutions

PanTHERA CryoSolutions has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include BioLife Solutions and Casdin Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investing in Life Sciences sectors like Healthcare and Biotechnology.
Founded Year Domain Location
Tissue hypothermic storage and cryopreservation freeze media are developed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by PanTHERA CryoSolutions

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - PanTHERA CryoSolutions

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Panthera Cryosolutions Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of PanTHERA CryoSolutions

PanTHERA CryoSolutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Brooks Automation, Bridge to Life, Hemanext, Atelerix and Cellbox Solutions, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Vacuum robots for semiconductor wafer handling are developed.
domain founded_year HQ Location
Cold storage solutions for organ transplant preservation are provided.
domain founded_year HQ Location
Technologies for blood and product storage are developed.
domain founded_year HQ Location
Technology for cell storage and transportation is developed.
domain founded_year HQ Location
Portable devices for cell storage and transport are provided.
domain founded_year HQ Location
Thermal packaging solutions and cold chain monitoring services are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Panthera Cryosolutions

Frequently Asked Questions about PanTHERA CryoSolutions

When was PanTHERA CryoSolutions founded?

PanTHERA CryoSolutions was founded in 2018 and raised its 1st funding round 2 years after it was founded.

Where is PanTHERA CryoSolutions located?

PanTHERA CryoSolutions is headquartered in Edmonton, Canada. It is registered at Edmonton, Alberta, Canada.

Is PanTHERA CryoSolutions a funded company?

PanTHERA CryoSolutions is a funded company, having raised a total of $6M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2M, raised on Dec 03, 2020.

What does PanTHERA CryoSolutions do?

PanTHERA CryoSolutions was founded in 2018 in Edmonton, Canada, within the biotechnology sector. Technology for cryopreserving cells, tissues, and organs is offered through a patented small molecule ice crystal inhibitor (IRI). Cellular function is preserved during prolonged frozen storage, with reductions in toxicity, stress, and ice crystal development. Dependence on DMSO, liquid nitrogen, and sample thawing is decreased in biological applications.

Who are the top competitors of PanTHERA CryoSolutions?

PanTHERA CryoSolutions's top competitors include Brooks Automation, Hemanext and Bridge to Life.

What products or services does PanTHERA CryoSolutions offer?

PanTHERA CryoSolutions offers Ice Recrystallization Inhibitors.

Who are PanTHERA CryoSolutions's investors?

PanTHERA CryoSolutions has 2 investors. Key investors include BioLife Solutions, and Casdin Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available